Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00300183 · ClinicalTrials.gov registry record
Evaluation of an HIV Outreach Program
A clinical trial, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- 150
- Enrollment target
NCT00300183: Completed study, sponsored by Montefiore Medical Center.
NCT00300183 is a clinical trial that has completed, run by Montefiore Medical Center. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00300183 has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
This study evaluates outreach to HIV-infected people living in unstable housing in New York City who are new to CitiWide Harm Reduction. One hundred and fifty people are interviewed every 6 months, and their medical records are reviewed every 6 months for a total of 18 months. The study examines how outreach, case management, housing, drug use, mental health, and quality of life are related to people's ability to get into and stay in medical care.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2003-10 |
| Est. Completion | 2005-07-31 |
What the finished NCT00300183 record still lists
NCT00300183 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00300183 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00300183 about?
NCT00300183 is a clinical study titled "Evaluation of an HIV Outreach Program". This study evaluates outreach to HIV-infected people living in unstable housing in New York City who are new to CitiWide Harm Reduction. One hundred and fifty people are interviewed every 6 months, and their medical records are reviewed every 6 months for a total of 18 months. The study examines how...
What is the current status of trial NCT00300183?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2003-10. Estimated completion is 2005-07-31.
Who is sponsoring clinical trial NCT00300183?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia